Our Learning
We at the Mueller Health Foundation strongly believe in sharing our lessons learned with our community. It is important to us to share insights on our successes, but also to identify opportunities for improvement to continuously better our projects and relationships.
Annual Report 2023
Our hope is to live in a world
where every person has access to
effective treatment options for
infectious diseases and infectious
diseases ultimately become
eradicated.
Annual Report
Our hope is to live in a world
where every person has access to
effective treatment options for
infectious diseases and infectious
diseases ultimately become
eradicated.
Annual Report
“Our hope is to live in a world
where every person has access to
effective treatment options for
infectious diseases and infectious
diseases ultimately become
eradicated.”
Annual Report
Our hope is to live in a world where every person has access to effective treatment options for infectious diseases and infectious diseases ultimately become eradicated
TUBERCULOSIS IN THE CROSSHAIRS
A team of innovators taps artificial intelligence and data analytics to battle an ancient foe.
TB Prevention
For latent TB, the most common preventive therapy is a daily dose of isoniazid (INH) taken as a single daily pill for 6 to 9 months. For active TB disease the treatment will likely be a combination of several drugs for 6 to 12 months. If the strain of TB is multi-drug resistant, the drugs initially used to treat TB will no longer be able to fight the TB germs in the body. The Mueller Health Foundation is currently working on supporting research into treatment options for multi-drug reistant TB.